Volume 25, Number 9—September 2019
CME ACTIVITY - Synopsis
Classification of Trauma-Associated Invasive Fungal Infections to Support Wound Treatment Decisions
Table 2
Characteristic | IFI |
p value | ||
---|---|---|---|---|
Proven, n = 40 | Probable, n = 30 | Possible, n = 24 | ||
Blast injury | 40 (100) | 29 (96.7) | 23 (95.8) | 0.327 |
Injured while on foot patrol† |
29 (100) |
26 (96.3) |
18 (85.7) |
0.062 |
Injury severity score | ||||
Median (IQR) | 42 (33–57) | 40 (33–50) | 35 (30–44) | 0.127 |
>26/critical |
39 (97.5) |
27 (90.0) |
21 (87.5) |
0.279 |
Blood units received 24 h after injury‡ | ||||
Median (IQR) | 31 (23–43) | 34 (23–47) | 27 (17–37) | 0.276 |
10–20 units | 6 (15.0) | 4 (13.3) | 8 (34.8) | 0.121 |
>20 units |
33 (82.5) |
24 (80.0) |
14 (60.9) |
0.074 |
Traumatic amputation§ |
30 (75.0) |
20 (66.7) |
14 (58.3) |
0.376 |
SOFA score, median (IQR) | ||||
Germany | 11 (8–15) | 10.5 (7–12) | 11 (5–12) | 0.413 |
US hospital |
9 (5–13) |
7.5 (1–11) |
4.5 (1–7.5) |
0.007 |
Duration of antifungal use, median (IQR) |
36 (23–49) |
24 (18–36) |
16 (0–24) |
<0.001 |
Outcome | ||||
Surgical amputations¶ | 27 (67.5) | 13 (43.3) | 10 (41.7) | 0.057 |
Death | 7 (17.5) | 1 (3.3) | 0 | 0.030 |
*Values are no. (%) except as indicated. IFI, invasive fungal wound infections; IQR, interquartile range; SOFA, sequential organ failure assessment.
†Status of whether patient was on foot patrol or in a vehicle is missing for 17 IFI patients (11 Proven, 3 Probable, and 3 Possible). Percentages and p-values based on total minus missing.
‡Blood information is missing for 1 patient with a possible IFI. Percentages and p-values based on total minus missing.
§Includes amputations that occurred before admission to a US hospital.
¶Defined as amputations that occurred after admission to a US hospital.
Page created: August 20, 2019
Page updated: August 20, 2019
Page reviewed: August 20, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.